HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jose M Ayuso Selected Research

Waste Products (Waste Product)

1/2021Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion.
11/2020Microfluidic Tumor-on-a-Chip Model to Study Tumor Metabolic Vulnerability.
10/2019Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients.
11/2018Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jose M Ayuso Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 10/2016
4Breast Neoplasms (Breast Cancer)
03/2021 - 11/2019
3Starvation
10/2019 - 01/2017
3Glioma (Gliomas)
01/2019 - 01/2016
2Hypoxia (Hypoxemia)
01/2021 - 11/2018
1Infections
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2022
1Necrosis
10/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Genomic Instability
11/2018
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2018
1Mental Disorders (Mental Disorder)
04/2013
1Alzheimer Disease (Alzheimer's Disease)
04/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2013

Drug/Important Bio-Agent (IBA)

4Waste Products (Waste Product)IBA
01/2021 - 11/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2018
3CollagenIBA
01/2021 - 01/2019
3Oxygen (Dioxygen)IBA
10/2019 - 10/2016
3HydrogelsIBA
10/2019 - 11/2018
2Pharmaceutical PreparationsIBA
11/2019 - 01/2019
2Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 06/2016
2DNA (Deoxyribonucleic Acid)IBA
06/2016 - 04/2013
1CytokinesIBA
01/2022
1cabozantinibIBA
01/2022
1Cancer VaccinesIBA
03/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1ChemokinesIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
11/2020
1Estrogen ReceptorsIBA
01/2020
1coenzyme Q10 (CoQ10)IBA
01/2019
1AntioxidantsIBA
01/2019
1AntibodiesIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1ProdrugsIBA
11/2018
1Tirapazamine (SR 4233)IBA
11/2018
1Phenobarbital (Luminal)FDA Link
11/2018
1Carmustine (FIVB)FDA Link
06/2016
1Histones (Histone)IBA
04/2013
1Amyloid (Amyloid Fibrils)IBA
04/2013
1polyanionsIBA
04/2013
1Peptides (Polypeptides)IBA
04/2013
1Polyglutamic Acid (Polyglutamate)IBA
04/2013
1MyoglobinIBA
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1Lactoglobulins (beta-Lactoglobulin)FDA Link
04/2013
1Bovine Serum AlbuminIBA
04/2013
1Heparin (Liquaemin)FDA LinkGeneric
04/2013
1Caseins (Casein)FDA Link
04/2013

Therapy/Procedure

8Therapeutics
01/2022 - 01/2016
3Immunotherapy
03/2021 - 01/2019
3Lab-On-A-Chip Devices
11/2020 - 01/2017
1Precision Medicine
03/2021
1Drug Therapy (Chemotherapy)
11/2019
1Photochemotherapy (Photodynamic Therapy)
11/2019